(Q39894159)

English

Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darby canine kidney cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

7

object named as

Takato Odagiri

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Keiichi Makizumi

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Kazuhiko Kimachi

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Katsuhiko Fukada

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Tomohiro Nishimura

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yasuhiro Kudo

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Shuro Goto

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Masato Tashiro

8

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Yoichiro Kino

9

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

6852-6858

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Gene composition of high-yielding influenza vaccine strains obtained by recombination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Canine MDCK cell lines are refractory to infection with human and mouse prions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Yield increases in intact influenza vaccine virus from chicken allantoic fluid through isolation from insoluble allantoic debris.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Dye terminator re-cycle-sequencing method: phage plaque direct sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Antibody responses after dose-sparing intradermal influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Generation of influenza A viruses entirely from cloned cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

Direct reverse transcriptase PCR to determine virulence potential of influenza A viruses in birds.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.075

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.09.075

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39894159&oldid=2092240983"